// Index Comparison
ACCE Cybersecurity vs ACCE Quality Compounders
Head-to-head: performance, risk profile, and constituent overlap between two ACCE indices.
US
ACCE Cybersecurity →
Zero-trust adoption, cloud security, and identity protection. The cybersecurity spend cycle is structural, not cyclical.
US
ACCE Quality Compounders →
High-ROIC, wide-moat businesses compounding shareholder value through pricing power, network effects, and recurring revenue.
ACCE Cybersecurity — risk
Volatility 30d+46.2%
Volatility 90d+42.2%
Sharpe 90d-0.13
Max drawdown-24.3%
Beta vs CIBR0.94
ACCE Quality Compounders — risk
Volatility 30d+24.4%
Volatility 90d+23.5%
Sharpe 90d-2.08
Max drawdown-22.8%
Beta vs SPY0.56
Constituent overlap
0 stocks held by both indices (out of 5 and 6)
Top sectors — ACCE Cybersecurity
Technology100.0%
Top sectors — ACCE Quality Compounders
Technology35.4%
Financial Services29.9%
Consumer Defensive19.4%
Healthcare15.4%
ACCE Verdict
**ACCE Cybersecurity** has outperformed **ACCE Quality Compounders** since inception, losing just 3.14% compared to Quality Compounders' brutal 13.67% decline, though both trail the benchmark's 4.74% gain.
The risk profiles tell opposite stories: Cybersecurity runs hot with 42.20% volatility but maintains a respectable -0.13 Sharpe ratio, while Quality Compounders keeps volatility contained at 23.46% but suffers from a catastrophic -2.08 Sharpe ratio despite similar maximum drawdowns around 23-24%.
Both indices target structural growth themes but through different lenses—Cybersecurity bets on the zero-trust security transformation while Quality Compounders hunts for wide-moat businesses with pricing power and network effects.
**Cybersecurity wins this matchup decisively.** Despite its higher volatility, it delivers meaningfully better returns with superior risk-adjusted performance. Quality Compounders' lower beta (0.56 vs 0.94) provides some downside protection, but the massive underperformance and terrible Sharpe ratio make it unsuitable for most portfolios right now. Cybersecurity suits investors comfortable with sector concentration and higher volatility in exchange for exposure to a structural spending cycle. Quality Compounders needs time to prove its thesis works in practice.